Estée Lauder Advanced Night Repair Moisturizing Overnight Treatment with Hyaluronic Acid, 2.2 Ounce

Helps skin look like it got 2 nights of sleep in 1.(1) This leave-on Overnight Skin Treatment cocoons skin with its silky, second-skin texture. Visibly activates age recovery every night: Plumps with quenching moisture. Strengthens skin’s barrier. Reduces the look of lines. Skin awakens with a radiant, recharged, energized look. One night, triple recovery: Moisture +58%(2), Barrier +40%(3), Visible Energy +28%(4). 95% said skin feels recharged upon waking.(5) ONE-NIGHT TRANSFORMATION: Building on 40 years of night science, this Overnight Skin Treatment is specifically formulated to visibly recharge skin and harness skin’s own overnight power, so every morning you awaken to a fresher, more recovered look. In just 1 night, skin looks: 13% smoother, 28% more radiant, 13% less lined.(4) SECOND-SKIN MASTERPIECE: Overnight Skin Treatment melts upon application, molding into skin to create a breathable, cocooning, second-skin seal. Locks in your nighttime skincare regimen to help optimize visible age recovery. Plus, it’s appropriate for post-IPL procedure use(6) and for fragile, sensitive skin. INCLUDES ADVANCED NIGHT REPAIR SERUM ACTIVES & MORE: Exclusive Night Peptide helps optimize skin’s natural rhythm of renewal. ATPower™ Technology boosts skin’s visible energy. Multi-Molecular Weight Hyaluronic Acid + Polyglutamic Acid (PGA) for intense moisture recovery. 13% Lipid Infusion for powerful barrier recovery. For all ages, all skintones, all skintypes. (1)72% agreed in consumer testing on 127 women who identify as poor sleepers after 4 weeks product use nightly. (2)Clinical testing on 26 women, after 1 product application. (3)Clinical testing on 32 women, 2 hours after 1 product application. (4)Clinical testing on 33 women, 12 hours after a single nighttime product application. (5)Consumer testing on 163 women after using product for 4 weeks, nightly. (6)Used starting within 36 hours after Intense Pulsed Light (IPL) treatment in a 2 week clinical usage test on 33 panelists.